According to a recent study, your likelihood of surviving gastric cancer may be influenced by the bacteria in your stomach. In a study that examined the bacteria in tumorous and healthy tissue from 71 gastric cancer patients, it was discovered that the presence of specific bacterial species, such as Fusobacterium and Prevotella, was linked to a worse prognosis.
Particularly, a Fusobacterium species known as F. nucleatum was closely associated with a poorer outcome. This suggests that F. nucleatum could be a potential target for fresh therapies.
The research also shown how intricately F. nucleatum interacts with other bacteria in the stomach.
We learn new things about how the stomach microbiome affects cancer, despite the study’s size and the need for more research. Antibiotics or bacteriophages may be used in the future to target harmful bacteria and enhance patient outcomes. https://doi.org/10.1038/s41598-023-31740-3
GIbiome 